The NIH Common Fund Metabolomics Program recently issued four new Funding Opportunity Announcements (FOAs) for the program’s second stage of funding. These funding opportunities will focus on the following topics:
- The continued development of a robust National Metabolomics Data Repository to store, and make publicly available, raw and processed metabolomic data generated by NIH-funded research. (RFA-RM-17-011)
- The development of novel tools to facilitate metabolomics data analysis and interpretation (RFA-RM-07-012)
- The establishment of Compound Identification Development Cores to develop innovative approaches to enhance compound identification of the most significant, biomedically-relevant unknown metabolites (RFA-RM-17-013)
- The establishment of a Stakeholder Engagement and Program Coordination Center to coordinate the required activities of the Common Fund Metabolomics Consortium and engage invested communities in developing and disseminating consensus best practices and data sharing policies in metabolomics (RFA-RM-17-014)
Letters of intent are due by September 12, 2017 and final applications are due by October 20, 2017. Please share with your colleagues who may be interested.
The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices.